NEW ORLEANS – Evidence on the use of cannabis for medical conditions is limited, so clinicians should be cautious when discussing it with patients, Kevin P. Hill, MD, MHS, said at the American Psychological Association annual meeting.
Hill, director of the division of addiction psychiatry and associate professor of psychiatry at Beth Israel Deaconess Medical Center/Harvard Medical School, participated in a panel discussion on medical marijuana.
“We’re in a critical period,” he said. “There is some evidence supporting the use of cannabinoids for medical indications.